How to Help Your Patients Find Contrave in Stock: A Provider's Guide

Helping Patients Access Contrave: A Practical Provider Guide

You've assessed your patient, discussed weight-management options, and determined that Contrave (Naltrexone 8 mg / Bupropion 90 mg ER) is the right fit. Now comes an increasingly common challenge: making sure they can actually fill the prescription.

Contrave is not in shortage, but its brand-name-only status, high retail cost, and inconsistent pharmacy stocking mean patients frequently encounter barriers. This guide gives you five actionable steps to help your patients access Contrave, along with alternative options and workflow tips to streamline the process.

Current Availability: What You Need to Know

Key facts about Contrave availability in 2026:

• Not on FDA shortage list — supply from Currax Pharmaceuticals is stable
• No generic available — brand-name only, single manufacturer
• Pharmacy stocking is inconsistent — many locations don't carry it due to low demand and high wholesale cost
• Retail price: $700–$900/month — creates cost barriers that reduce pharmacy stocking incentives
• Insurance coverage: ~30–40% of commercial plans — most require prior authorization

Why Patients Can't Find It

Understanding the patient experience helps you intervene effectively:

1. Chain pharmacies use automated inventory — if a location fills few Contrave prescriptions, the system may not restock it
2. Patients call multiple pharmacies — each says "we don't carry that" or "we can order it in 3–5 days"
3. Cost shock at the counter — patients without coverage discover the $700+ price and walk away
4. Prior auth delays — unsubmitted or incomplete PAs lead to weeks of waiting
5. Patients lose motivation — the friction of the process can derail a patient's weight-management commitment

Your intervention at the prescribing stage can prevent most of these barriers.

What Providers Can Do: 5 Steps

Step 1: Check Pharmacy Stock Before Prescribing

Before sending the prescription, check whether the patient's pharmacy has Contrave in stock. Medfinder for providers shows real-time availability at pharmacies near your patient. This takes less than a minute and can save days of patient frustration.

If the patient's preferred pharmacy doesn't have it, identify one that does and send the prescription there.

Step 2: Submit Prior Authorization Proactively

Don't wait for the pharmacy to request a PA. If you know the patient's insurance requires it, submit it at the time of prescribing. Include:

• Current BMI and body weight
• Weight-related comorbidities (type 2 diabetes, hypertension, dyslipidemia)
• Documentation of previous diet/exercise interventions
• Clinical rationale for Contrave (oral medication, not a controlled substance, targets both appetite and cravings)

Having a standardized PA template for weight-management medications can significantly speed up this process.

Step 3: Educate Patients About the CurAccess Program

Currax Pharmaceuticals' CurAccess Patient Support Program is often the best option for patients, especially those without insurance coverage:

• Contrave for $99/month or less
• Free home delivery through Ridgway Mail Order Pharmacy
• Enrollment available at contrave.com/save

For commercially insured patients, Currax also offers copay savings cards that can reduce out-of-pocket costs to $99 per fill (covering copay amounts up to $446.40).

Consider having printed information about CurAccess in your office or incorporating it into your after-visit summary.

Step 4: Recommend Independent or Mail-Order Pharmacies

If local chain pharmacies consistently don't stock Contrave, recommend:

• Independent pharmacies — more flexibility in inventory management and ordering
• Mail-order pharmacies — both through the CurAccess program and through the patient's insurance (if covered)
• Specialty pharmacies — some carry a wider range of brand-name products

Step 5: Set Fill Expectations at the Visit

Let patients know upfront that Contrave may require extra steps to fill:

• "Your pharmacy may need to order it — this usually takes 1–2 days"
• "I'm submitting a prior authorization today so insurance can process it"
• "Here's information on the CurAccess program if cost is a concern"
• "Use Medfinder to check which pharmacies near you have it in stock"

Setting expectations prevents the frustration that leads to patients abandoning treatment.

Alternative Medications to Consider

If Contrave is not accessible for a specific patient — due to cost, contraindications, or preference — here are other FDA-approved options:

• Qsymia (Phentermine/Topiramate ER): Oral combination, ~$200–$250/month. Schedule IV. May produce greater weight loss. Contraindicated in pregnancy.
• Orlistat (Xenical/Alli): Lipase inhibitor, $40–$300/month. GI side effects common. Available OTC (Alli 60 mg).
• Saxenda (Liraglutide 3 mg): Daily injectable GLP-1 agonist, $1,000–$1,400/month. Good for patients who also have type 2 diabetes.
• Wegovy (Semaglutide 2.4 mg): Weekly injectable GLP-1 agonist, $1,300–$1,600/month. Highest weight-loss efficacy among available options.
• Zepbound (Tirzepatide): Weekly dual GIP/GLP-1 agonist. Newest option. Supply improving.

For patient-facing information, direct patients to our alternatives to Contrave article.

Workflow Tips for Your Practice

Here are ways to make prescribing Contrave smoother in your practice:

Create a Weight-Management Medication Checklist

For each patient starting Contrave, work through:

1. Confirm no contraindications (seizure history, eating disorders, opioid use, MAOIs, pregnancy)
2. Check insurance coverage / submit PA
3. Verify pharmacy stock via Medfinder
4. Provide CurAccess program information
5. Schedule follow-up at 4 weeks (end of titration) and 12 weeks (efficacy evaluation)

Titration Reminder

Contrave uses a 4-week titration schedule:

• Week 1: 1 tablet in the morning
• Week 2: 1 tablet AM, 1 tablet PM
• Week 3: 2 tablets AM, 1 tablet PM
• Week 4+: 2 tablets AM, 2 tablets PM (maintenance: 32 mg Naltrexone / 360 mg Bupropion daily)

Evaluate at 12 weeks: if the patient has not lost ≥5% of baseline body weight, discontinue Contrave.

Track Patient Outcomes

Documenting weight-loss outcomes by medication can help with future prior authorization requests and inform your prescribing patterns.

Final Thoughts

Contrave is a valuable oral option for weight management — the only FDA-approved combination pill that targets both appetite and cravings without controlled substance scheduling. The access barriers are real but solvable.

By checking stock before prescribing with Medfinder, submitting prior authorizations proactively, and connecting patients with the CurAccess savings program, you can significantly improve your patients' experience and treatment adherence.

For the current supply picture and a broader market overview, see our Contrave shortage briefing for providers.

For cost-saving strategies to share with patients, see: How to help patients save money on Contrave.